Alaa HalawaDirector at Mubadala Ventures
Alaa Halawa is an investor in the San Francisco Bay Area-based venture capital business of Mubadala Capital (“Mubadala Ventures”), where he focuses on investing in venture and early growth-stage companies at the intersection of life sciences and technology. Among other themes within life sciences investing, Alaa has concentrated on the following: how technology is enhancing the pharmaceutical industry, from drug discovery through clinical trials; how technology – and in particular bio-informatics, artificial intelligence and machine learning – is enhancing disease diagnosis; and how technology is enhancing clinical and non-clinical workflow in hospitals and clinics. Prior to Mubadala Ventures, Alaa started his career working for a telecom solutions start-up company where he was responsible for product management and marketing. During his tenure, Alaa worked on expanding the product portfolio from a single product to a suite of 10 platforms that target critical services for mobile operators. Alaa joined Mubadala in 2009 where he worked on designing and implementing the strategy to develop a technology cluster in Abu Dhabi focusing on semiconductor research through partnerships with Silicon Valley companies and academic institutions. Following the design and the initial roll-out of the strategy, Alaa moved to the Bay Area to support the transition of Executive Leadership in one of Mubadala's key assets in Silicon Valley, GlobalFoundries, where he worked on a series of strategic, corporate development and transformation initiatives. Alaa holds an MBA from Cornell University and a Bachelor of Science in Electrical Engineering from University of Jordan.